InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company

2 Dividend Kings to Buy for a Lifetime of Passive Income

Major companies that are also popular short-selling stocks

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?

Inside a $400 billion bet on the brain-computer interface revolution

Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024

Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years